Open AccessClinical significance and prognostic value of tumor necrosis factor-α and dickkopf related protein-1 in ankylosing spondylitis
Author(s) -
Jun-hui Xiong,
Jian Liu,
Jian Chen
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i7.1213
Subject(s) - medicine , ankylosing spondylitis , tumor necrosis factor alpha , clinical significance , gastroenterology , tumor necrosis factor α , rheumatology , population , receiver operating characteristic , spondylitis , etanercept , epidemiology , oncology , environmental health
Ankylosing spondylitis (AS) frequently occurs in people aged 30-45 years, and its prevalence is generally believed to be between 0.1% and 1.4% globally. At present, the "gold standard" for diagnosis of AS requires the provision of pelvic X-rays, which makes it more difficult to perform in population-based epidemiological studies. Therefore, the identification of serological indicators related to the diagnosis, treatment, and prognosis of AS patients is of great significance.